Evidence map›Paper›PMID 17620387›Full record

ArticleThe Journal of molecular diagnostics : JMD2007

Ewing sarcoma with novel translocation t(2;16) producing an in-frame fusion of FUS and FEV.

Tony L Ng, Maureen J O'Sullivan, Catherine J Pallen, Malcolm Hayes, Paul W Clarkson, Mark Winstanley, Poul H B Sorensen, Torsten O Nielsen, Douglas E Horsman

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in The Journal of molecular diagnostics : JMD, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 156 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Ewing sarcoma from molecular biology to the clinic.Frontiers in cell and developmental biology · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Identification of a NovelMolecular cancer research : MCR · 2021
    Article
  13. Review
  14. Article
  15. Article
  16. Molecular Approaches to Diagnosis in Ewing Sarcoma: RT-PCR.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Tony L NgDepartment of Pathology and Laboratory Medicine, British Columbia Cancer Agency, 600 W. 10th Ave., Vancouver, BC, Canada, V5Z 4E6.
Maureen J O'Sullivan
Catherine J Pallen
Malcolm Hayes
Paul W Clarkson
Mark Winstanley
Poul H B Sorensen
Torsten O Nielsen
Douglas E Horsman
University of British Columbia · CABC Cancer Agency · CABC Children's Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ewing family tumors are molecularly characterized by expression of chimeric transcripts generated by specific chromosomal translocations, most commonly involving fusion of the EWS gene to a member of the ETS family of transcription factors (including FLI1, ERG, ETV1, E1AF, and FEV). Approximately 85% of reported cases of Ewing sarcoma bear an EWS-FLI1 fusion. In rare cases, FUS can substitute for EWS, with translocation t(16;21)(p11;q24) producing a FUS-ERG fusion with no EWS rearrangement. We report a case of Ewing sarcoma, presenting as a pathological fracture of the distal clavicle in a 33-year-old male, in which cytogenetic analysis revealed a single t(2;16)(q35;p11) balanced translocation. Fluorescence in situ hybridization using a commercially available diagnostic probe was negative for an EWS gene rearrangement; instead, break-apart fluorescence in situ hybridization probes for FUS and FEV were positive for a translocation involving these genes. Cloning and sequencing of the breakpoint region demonstrated an in-frame fusion of FUS to FEV. In conclusion, this represents the first reported case of Ewing family tumors demonstrating a variant translocation involving FUS and FEV and highlights the need to consider alternative permutations of fusion partners for molecular diagnosis of sarcomas.

Indexed as

AdultBase SequenceChromosomes, Human, Pair 16Chromosomes, Human, Pair 2HumansImmunohistochemistryIn Situ Hybridization, FluorescenceMaleMetaphaseMolecular Sequence DataOligonucleotide Array Sequence AnalysisOncogene Proteins, FusionSarcoma, EwingSequence Analysis, DNATranslocation, GeneticEWS-FEV fusion protein, humanEWS-FUS protein, humanOncogene Proteins, Fusion

Identifiers

PMID17620387
PMCPMC1975098
OpenAlexW2076107852

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.